Internal Medicine, Nephrology · Philadelphia, PA
NPI
1366968356
Since 2017
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3401 N Broad St
Philadelphia, PA, 19140
Phone (267) 530-3144
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
736 services
Medicare patients, 2024
261
Average age 56
Drug cost, 2024
$1.0M
4,760 prescriptions
Company payments, 2025
$104
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ruchi H Naik was code 99215 (office e&m - established), 404 times for 163 patients. In total Ruchi H Naik billed 736 services in 12 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 404 | 163 | $110.17 | $45K |
| 99233 Hospital E&M - Subsequent | Facility | 127 | 50 | $94.09 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 81 | 28 | $64.17 | $5,198 |
| 99443 Telephone Services | Office | 60 | 46 | $98.62 | $5,917 |
| 99222 Hospital E&M - Initial | Facility | 24 | 24 | $109.39 | $2,625 |
| 99221 Hospital E&M - Initial | Facility | 22 | 21 | $64.64 | $1,422 |
By year: 2022 $96K for 1,215 services; 2023 $96K for 959 services; 2024 $73K for 736 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ruchi H Naik prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 509 prescriptions and refills. In total Ruchi H Naik wrote 4,760 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 509 | 892 | 113 | $1,381 |
| Prednisone Generic | 371 | 493 | 75 | $1,540 |
| Carvedilol Generic | 358 | 619 | 80 | $1,925 |
| Atorvastatin Calcium Generic | 290 | 522 | 62 | $1,918 |
| Nifedipine Er Nifedipine | 242 | 406 | 57 | $4,899 |
| Atovaquone Generic | 225 | 252 | 42 | $113K |
| Cinacalcet Hcl Generic | 169 | 244 | 28 | $49K |
| Furosemide Generic | 161 | 247 | 50 | $656 |
| Valganciclovir Hcl Generic | 154 | 183 | 57 | $59K |
| Amlodipine Besylate Generic | 145 | 252 | 37 | $581 |
| Pantoprazole Sodium Generic | 122 | 201 | 26 | $836 |
| Lisinopril Generic | 109 | 214 | 27 | $311 |
| Famotidine Generic | 106 | 155 | 19 | $380 |
| Metoprolol Succinate Generic | 90 | 132 | 16 | $1,042 |
| Envarsus Xr Tacrolimus | 82 | 122 | 17 | $124K |
Brand drugs: 398 claims; generic drugs: 4,316 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ruchi H Naik $104 ($104 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novartis Pharmaceuticals Corporation with $60.27.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.